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Abstract
Neuropeptide Y (NPY) acting in the hypothalamus is one of the most powerful orexigenic agents known. Of the five known
Y receptors, hypothalamic Y1 and Y5 have been most strongly implicated in mediating hyperphagic effects. However,
knockout of individual Y1 or Y5 receptors induces late-onset obesity – and Y5 receptor knockout also induces hyperphagia,
possibly due to redundancy in functions of these genes. Here we show that food intake in mice requires the combined
actions of both Y1 and Y5 receptors. Germline Y1Y5 ablation in Y1Y52/2 mice results in hypophagia, an effect that is at least
partially mediated by the hypothalamus, since mice with adult-onset Y1Y5 receptor dual ablation targeted to the
paraventricular nucleus (PVN) of the hypothalamus (Y1Y5Hyp/Hyp) also exhibit reduced spontaneous or fasting-induced food
intake when fed a high fat diet. Interestingly, despite hypophagia, mice with germline or hypothalamus-specific Y1Y5
deficiency exhibited increased body weight and/or increased adiposity, possibly due to compensatory responses to gene
deletion, such as the decreased energy expenditure observed in male Y1Y52/2 animals relative to wildtype values. While Y1
and Y5 receptors expressed in other hypothalamic areas besides the PVN – such as the dorsomedial nucleus and the
ventromedial hypothalamus – cannot be excluded from having a role in the regulation of food intake, these studies
demonstrate the pivotal, combined role of both Y1 and Y5 receptors in the mediation of food intake.
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Introduction
A major obstacle in the treatment of overweight and obesity is
hunger. Loss of as little as 6–14% of body weight by energy
restriction, with or without exercise, in obese men and women
significantly increases appetite [1]. This increase in appetite is a
significant predictor of subsequent weight regain in humans [2]
and in diet-induced obese rats [3]. Moreover, people carrying
obesity-risk genetic polymorphisms consistently show increases in
appetite or measured food intake [4]. In light of the key role of
appetite in determining energy balance, interventions that reduce
hunger could enable more people to attain and maintain a healthy
body weight.
Neuropeptide Y (NPY), a 36-amino acid peptide abundantly
expressed in the central and peripheral nervous systems, is one of
the most powerful orexigenic agents known. Continuous admin-
istration of NPY to the hypothalamus of normal animals results in
massive hyperphagia and obesity [5,6]. Importantly, many other
orexigenic and anorexigenic agents – such as leptin, glucocorti-
coids, melanocortins and ghrelin – mediate effects on food intake
and energy balance at least partially via the NPY-ergic system [7–
9]. This makes NPY and its receptors (Y1, Y2, Y4, Y5 and – in
mice – y6) possible targets for anti-obesity therapies.
Y1 and Y5 receptors have been strongly implicated in
mediating the hyperphagic effects of NPY or energy restriction
[10–12]. However, whereas male and female germline Y1 receptor
deficient mice exhibit reduced fasting-induced food intake, they
exhibit slight or no reductions in total daily food intake or NPY-
stimulated feeding, and they also develop late-onset obesity [13–
16]. Paradoxically, male and female germline Y5 receptor
knockout mice are obese with increases in total daily food intake,
fasting-induced food intake, body weight and adiposity, and they
are not protected against leptin-deficiency-induced obesity
[17,18]. Additionally, chronic intracerebroventricular NPY ad-
ministration to Y1 or Y5 receptor knockout mice induces a similar
hyperphagic obesity syndrome as that seen in wildtype mice [6].
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These observations might be attributed to compensatory effects of
germline gene deletion. Indeed, germline Y5 receptor knockouts
display exacerbated fasting-induced increases in hypothalamic
expression of the orexigenic NPY and agouti related peptide
(AgRP), and exacerbated decreases in that of proopiomelanocortin
(POMC, which produces the anorexigenic a-melanocyte stimu-
lating hormone, a-MSH) and the anorexigenic cocaine and
amphetamine-related transcript (CART) [18]. However, when
conditional deletion of hypothalamic Y1 receptors was induced in
adult mice in order to circumvent possible compensatory effects,
marked and significant effects on nesting and food scattering
behaviours were observed, but there was no effect on total daily
food intake or fasting-induced food intake [15]. Taken together,
these findings suggest redundancies between Y1 and Y5 receptors
in the control of energy homeostasis, in keeping with the
observation that the genes are coordinately regulated by the same
promoter region [19] and are co-expressed in the same neurons
[20–22].
In order to circumvent the possible redundancy between Y1
and Y5 receptors in the control of food intake and energy
homeostasis, we generated Y1Y5 receptor double knockout mice.
Moreover, in order to investigate the possible role of hypothalamic
Y1 and Y5 receptor signaling in the regulation of these processes,
we also generated conditional Y1Y5 receptor double knockout
mice (Y1Y5lox/lox) in which Y1 and Y5 receptors can be deleted in
one step in adult mice by injection of an adeno-associated viral
vector (rAAV) expressing Cre-recombinase. These germline and
adult-onset hypothalamus-specific Y1Y5 receptor knockout mice
were studied on a chow diet and on a high fat diet in order to
determine the role of Y1 and Y5 receptors in the regulation of
energy homeostasis.
Methods
Ethics Statement and Animal Care
All research and animal care procedures were approved by the
Garvan Institute/St Vincent’s Hospital Animal Ethics Committee
and were in agreement with the Australian Code of Practice for
the Care and Use of Animals for Scientific Purposes. All mice were
housed under conditions of controlled temperature (22uC) and
illumination (12 h light-dark cycle, lights on at 7:00 hours) with
ad libitum access to water and standard chow (8% calories from fat,
21% calories from protein, 71% calories from carbohydrates and
2.6 kcalories.g21; Gordon’s Specialty Stock Feeds, Yanderra, New
South Wales, Australia) unless otherwise stated.
Generation of Y1Y5 Double Knockout Mice
Due to the close proximity of the Y1 and Y5 genes, being
approximately only 20 kb apart [19], generation of double mutant
mice is very unlikely to be achieved by simple crossing of the single
knockout strains. Therefore a strategy of double targeting of
embryonic stem (ES) cells was used. Positively targeted ES cells
carrying the mutant Y1 allele were targeted again with a vector
containing a Y5 receptor gene flanked by loxP sites (floxed). In
order to be able to select for additional targeting events, a different
selection marker was used in this Y5 targeting vector (hygro-
mycin), versus the already existing neomycin resistant gene.
Standard Southern blot analysis was used to identify clones with
the correctly integrated Y5 targeting vector. Long range PCR was
then used to verify which of these clones actually had targeting
events on the same strand of DNA, as would be necessary for
coupled transmission of the mutant genes. Two ES cell lines
positive for targeting events of both Y1 and Y5 receptors on the
same strand of DNA were then injected into oocytes derived from
C57BL/6 mice to generate chimeric offspring and subsequent
heterozygous mice carrying the conditionally targeted genes
(Y1Y5lox/+). Crossing these mice with an oocyte-specific Cre-
expressing line, followed by crossing the respective heterozygous
offspring, then led to generation of both the germline and
conditional Y1 and Y5 double receptor knockout mice, termed
Y1Y52/2 and Y1Y5lox/lox, respectively. Both of these knockout
strategies are designed to result in deletion of the entire coding
region of the Y1 and Y5 receptors. All mice were on a mixed
C57BL/6-129/SvJ background. Absence of the Y1Y5 genes in
homozygous germline Y1Y52/2 mice was confirmed by PCR on
genomic DNA as described below and as shown in the results
section. The successful deletion of both genes by this cross also
provides verification for the functionality of the Cre-lox system, as
this targeted locus is important for the conditional deletion of these
genes described below.
Generation of Adult-onset Hypothalamus-specific Y1Y5
Receptor Knockout Mice
Y1Y5lox/lox mice at 12 weeks of age were anaesthetised with
100/20 mg/kg ketamine/xylazine (Parke Davis-Pfizer, Sydney,
Australia and Bayer AG, Leverkusen, Germany). With the head in
the flat skull position and using a stereotaxic table (David Kopf,
Tujunga, CA, USA), brain injection coordinates relative to
Bregma were posterior 0.94 mm, lateral 60.3 mm, ventral
4.75 mm, corresponding to the paraventricular nucleus (PVN) of
the hypothalamus [23]. A volume of 1 mL of viral vector (1 X 1010
plaque-forming units per mL) was injected bilaterally over 10
minutes using a 1-ml Hamilton syringe attached to a syringe
infusion pump (World Precision Instruments Inc, Walthan, MA,
USA). Injection with recombinant adeno-associated viral vector
(rAAV) expressing Cre-recombinase was used to produce hypo-
thalamus-specific Y1Y5 receptor knockout mice (Y1Y5Hyp/Hyp).
As controls, littermate Y1Y5lox/lox mice were injected with a GFP-
expressing adeno-associated viral vector.
High Fat Diet Intervention
At 16 weeks of age and 4 weeks after rAAV vector injection, half
of the Y1Y5Hyp/Hyp and Y1Y5lox/lox mice were fed a high fat diet
(23% calories from fat, 19.4% calories from protein, 48.2%
calories from carbohydrate, 4.7% calories from crude fibre, 4.7%
calories from acid detergent fibre, 4.78 kcalories.g21; Gordon’s
Specialty Feeds, Glen Forrest, WA, Australia) for 20 weeks. The
remaining mice continued on the standard chow diet.
Feeding Studies
Food intake was measured both in the fed state (referred to as
spontaneous food intake), as well as in response to 24-hour fasting
using Nalgene metabolic cages (Medtex, Notting Hill, VIC). Mice
were transferred to individual cages and were fed a powdered diet
for 3 days before being placed into individual Nalgene metabolic
cages. Spontaneous food intake was determined as the average of
triplicate readings taken over three consecutive 24-hour periods.
Twenty four-hour fasting-induced food intake was subsequently
measured at 1, 2, 4, 7, 24 and 48 hours after re-introduction of
food to the cages, and body weight was tracked throughout feeding
studies.
Glucose Metabolism in Hypothalamus-specific Y1Y5
Receptor Knockout Mice
At 18 and 35 weeks of age, corresponding to 6 and 23 weeks
after hypothalamic rAAV injection and 2 and 19 weeks on a high
fat diet, Y1Y5Hyp/Hyp and Y1Y5lox/lox control mice underwent an
Hypophagic Effect of Y1Y5 Receptor Deletion
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insulin tolerance test at 14:00 to 16:00 hours. Briefly, the mice
were fasted for 6 hours and then intraperitoneally injected with
insulin (0.5 IU/kg) (Novo Nordisk Pharmaceuticals, Baulkham
Hills, NSW, Australia). Tail tip blood samples were then collected
at 0, 15, 30, 45, 60, 75 and 90 minutes after insulin injection, and
blood glucose levels were measured using a glucometer (Accu-
Check II; Roche, New South Wales, Castle Hill, Australia). Four
days later, mice were fasted for 16 to 24 hours before
intraperitoneal injection between 13:00 to 15:00 hours of a 10%
D-glucose solution (1.0 g/kg) (Astra Zeneca, North Ryde, NSW,
Figure 1. Increased body weight/adiposity despite reduced food intake in Y1Y52/2 mice on chow. (A–H) Spontaneous (A, C, E, G) and
accumulated (accum) 24-hour fasting-induced food intake (B, D, F, H), normalised to body weight, in male and female germline Y1Y5 receptor
knockout (Y1Y52/2) and wildtype control (WT) mice at 18 and 34 weeks of age. (I–J) Body weight from 16 to 36 weeks of age in male (I) and female (J)
Y1Y52/2 or WT mice. (K–P) Fat and lean masses as a percentage of body weight (%BW), measured using dual energy x-ray absorptiometry, in male (K,
O) and female (M, P) Y1Y52/2 and WT mice at 20 and 36 weeks of age. Weight (as %BW) of dissected white (WAT) and brown adipose tissue (BAT)
depots at the end of the study in male (L) and female (N) Y1Y52/2 and WT mice at 36 weeks of age. Abbreviations: i, inguinal; g, gonadal; m,
mesenteric; r, retroperitoneal; total, summed weight of i, g, m and r WAT depots. Plotted values are means 6 SEM of 5–12 standard chow-fed mice
per group. *P,0.05, **P,0.01 or ***P,0.001 for Y1Y52/2 versus WT mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g001
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Australia). Blood samples were obtained from the tail tip at 0, 15,
30, 60 and 90 minutes after glucose injection and blood glucose
levels were measured using a glucometer.
Indirect Calorimetry
Energy expenditure and respiratory exchange ratio were
calculated by measurement of the rate of oxygen consumption
(VO2) and carbon dioxide output (VCO2) via indirect calorimetry
in ad libitum-fed mice using an eight-chamber open-circuit
calorimeter (Oxymax Series; Columbus Instruments, Columbus,
OH, USA) as previously described by us [16]. Physical activity was
also determined in the calorimetry cages using an OPTO-M3
sensor system (Columbus Instruments) as previously described
[16]. Studies were conducted after 24 hours of acclimatisation to
calorimetry chambers.
Determination of Body Composition
Upon completion of indirect calorimetry and physical activity
measurements, animals were anesthetised with isoflurane and then
scanned (with the head excluded and the tail included) using dual-
energy X-ray absorptiometry (DXA, Lunar PIXImus2 mouse
densitometer; GE Healthcare, Waukesha, WI, USA) to determine
whole body fat and lean mass.
Tissue Collection
At 36 weeks of age, mice were fasted from 09:00 hours and
culled between 13:00 to 17:00 hours by cervical dislocation
followed by decapitation. The brain was removed and frozen on
an aluminium plate on dry ice, then stored at 280uC until
analyses as described below. The interscapular brown adipose
tissue (BAT) as well as white adipose tissue (WAT) depots (right
inguinal, right epididymal or periovarian (gonadal), right retro-
peritoneal and mesenteric) were removed and weighed. The
weights of these WAT depots were summed together and
expressed as total WAT weight, normalised as a percent of body
weight.
Figure 2. Slower weight regain after a 24-hour fast in Y1Y52/2mice on chow. Body weight measurements were taken at the time points of
fasting-induced food intake measurements in male (A, C) and female (B, D) germline Y1Y5 receptor knockout (Y1Y52/2) or wildtype control (WT)
mice, at both 18 and 34 weeks of age. Data are presented as a percent of pre-fasting body weight (%basal). Absolute pre-fasting body weights at 18
weeks of age were WT male = 25.460.6 g; Y1Y52/2 male = 29.361.8 g; WT female = 19.760.5 g; Y1Y52/2 female = 20.160.4 g, and at 34 weeks of
age, WT male = 30.161.3 g; Y1Y52/2male = 35.561.2 g; WT female = 24.560.7 g; Y1Y52/2 female = 25.060.9 g. Plotted values are means6 SEM of
4–21 standard chow-fed mice per group. **P,0.01 or ***P,0.001 for Y1Y52/2 versus WT mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g002
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Polymerase Chain Reaction Confirmation of Germline
and Hypothalamus-specific Y1Y5 Receptor Deletion in
Y1Y52/2 and Y1Y5Hyp/Hyp Mice
Y1 and Y5 receptor deletion was confirmed using genomic DNA
isolated from various brain regions of Y1Y52/2 or Y1Y5Hyp/Hyp
mice. The brain tissue used for DNA extraction was dissected from
one of three regions: a section including the PVN, a section including
the olfactory bulb, and a section including the hypothalamic arcuate
nucleus. PCR was performed with the following primers: Oligo A,
59-CCATGAAGCATGTTGTGG-39; Oligo B, 59-ATTCTC-
TAGTCAAAGTGTC-39; Oligo C, 59-CTTGTAG-
CAAATTCCTGCAG-39; and Oligo D, 59-GCCAGAGATA-
GATTACAAAG-39. PCR with the combination of Oligos B and
C produces a 314 bp fragment representing the homozygous floxed
Y1Y5lox/lox genotype. Combination A and D produces a product of
150 bp only when the entire Y1Y5 gene cluster has been removed,
confirming successful deletion of both the Y1 and Y5 receptor gene.
Radioactive Ligand Binding Assay for Confirmation of
Successful Hypothalamus-specific Y1Y5 Receptor
Deletion and Determination of Total Y Receptor Binding
Coronal brain sections, 25 mm thick at the level of the PVN or
hypothalamic arcuate nucleus, were cut and thaw-mounted on
charged slides and stored at 220uC until radioactive ligand
binding assay as previously described [24]. In brief, sections were
incubated with 25 pM [125I]-PYY to demonstrate total Y receptor
binding, or with 25 pM [125I]-PYY with or without addition of
Figure 3. Reduced ARC NPY expression and increased body weight in young Y1Y52/2 mice on chow. (A–B) Bright field
photomicrographs of coronal brain sections from 15 week old male wildtype control (WT, A) and germline Y1Y5 receptor knockout (Y1Y52/2, B) mice
after in situ hybridisation for NPY mRNA. Scale bar = 25 mm. Abbreviations: 3V; third ventricle, ARC, arcuate nucleus of the hypothalamus. (C–D) Body
weight from 5 to 15 weeks of age in male (C) and 5 to 13 weeks of age in female (D) WT or Y1Y52/2 mice. Plotted values are means 6 SEM of 4–21
standard chow-fed mice per group. ***P,0.001 for Y1Y52/2 versus WT mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g003
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1 mM of the Y2 receptor antagonist BIIE0246, indicating the
degree to which Y2-receptor binding is altered.
In Situ Hybridisation for Quantification of Hypothalamic
NPY, POMC, TRH and Y1 and Y5 Receptor mRNA
Expression
Slides with frozen brain sections containing the arcuate nucleus
or PVN were thawed and hybridised with radiolabelled oligonu-
cleotides for quantification of mRNA levels as previously described
[25].
Statistical Analyses
All data are expressed as means 6 SEM. Differences between
knockout and control mice were assessed by ANOVA or repeated
measures ANOVA, with Fisher’s post hoc tests where appropriate.
Energy expenditure, respiratory exchange ratio and physical
activity over the continuous 24-hour period were averaged for the
whole 24-hour period, as well as for the light and dark periods.
Comparison of energy expenditure (kcal/hr) was carried out by
analysis of covariance (ANCOVA) with lean mass as a covariate.
Adjusted means of energy expenditure at a common lean mass
were generated by ANCOVA and presented. Statistical analyses
were performed with SPSS for Mac OS X version 16.0.1 (SPSS
Inc, Chicago, IL, USA). Statistical significance was defined as
P,0.05.
Results
Absence of Y1 and Y5 Signalling Reduces Spontaneous
and Fasting-induced Food Intake
Since pharmacological evidence suggests that both Y1 and Y5
receptors play a critical role in the regulation of food intake [10–
12], we first investigated spontaneous and fasting-induced food
Table 1. Hypothalamic neuropeptide expression in male
Y1Y52/2 mice on chow.
WT Y1Y52/2
ARC NPY mRNA 10066 68612*
ARC POMC mRNA 10064 9663
PVN TRH mRNA 10068 8868
Expression levels of mRNA for neuropeptide Y (NPY), proopiomelanocortin
(POMC) and thyrotropin releasing hormone (TRH) as determined by in situ
hybridisation in the arcuate nucleus of the hypothalamus (ARC) or the
hypothalamic paraventricular nucleus (PVN) in male wildtype control (WT) or
germline Y1Y5 receptor knockout (Y1Y52/2) mice at 15 weeks of age. mRNA
levels are expressed as relative optical density units, relative to that of WT. Data
are means 6 SEM of 4–6 male mice per group. *P,0.05 versus wildtype mice.
doi:10.1371/journal.pone.0040191.t001
Figure 4. Altered energy expenditure and decreased respiratory exchange ratio in Y1Y52/2mice on chow. (A–L) 24-hour time course of
energy expenditure (A–D), physical activity (E–H) and respiratory exchange ratio (I–L) in male and female germline Y1Y5 receptor knockout (Y1Y52/2)
or wildtype control (WT) mice at 20 and 36 weeks of age. Energy expenditure was adjusted for lean mass by analysis of covariance (ANCOVA).
Adjusted energy expenditure was presented at a common lean mass of 21.936 g (males) and 16.015 g (females) at 20 weeks of age and 23.172 g
(males) and 17.115 g (females) at 36 weeks of age. Open and filled horizontal bars indicate light and dark phases, respectively. Plotted values are
means 6 SEM of 5–12 standard chow-fed mice per group. *P,0.05, **P,0.01, or ***P,0.001 for Y1Y52/2 versus WT mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g004
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Figure 5. Successful deletion of hypothalamic Y1Y5 receptors from adult mice. (A) Top left: Schematic diagram of proposed injection site
just outside the PVN (adapted with permission from [23]). Top right: Coronal brain section showing the position of needles used to inject Cre-
recombinase- or GFP-expressing viral vector into the brain, as shown by the Bromophenol blue-stained needle tracks at X. By targeting delivery to
just outside the PVN, the nucleus is undamaged by the needle tip but viral vector can diffuse through it. Bottom left: Coronal brain section
demonstrating the localised expression (indicated by fluorescence) of the GFP-expressing viral vector targeted to just outside of the PVN. Bottom
right: Localised fluorescence from the image at bottom left seen at higher magnification. (B) Targeting vector design illustrating loxP sites flanking
the Y1 and Y5 receptor genes. Small arrows indicate the position and orientation of oligonucleotides used in PCR analysis. Inset: PCR analysis of
genomic DNA isolated from sections of the hypothalamus containing the PVN (H), olfactory bulb (O) or the arcuate nucleus (A) of two wildtype (WT),
two germline Y1Y5 receptor knockout (Y1Y52/2) mice, or a conditional knockout Y1Y5lox/lox mouse injected with a Cre-recombinase-expressing viral
vector into the PVN (Y1Y5Hyp/Hyp). When oligonucleotides B+C are used, a PCR product is clearly produced in DNA isolated from the PVN (H) of WT
mice, and in DNA isolated from the olfactory bulb (O) or arcuate nucleus (A) from Y1Y5Hyp/Hyp mice, demonstrating the presence of intact Y1Y5
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intake in germline Y1Y5 double knockout mice. Importantly, male
Y1Y52/2 mice at both 18 and 34 weeks of age showed
significantly decreased spontaneous food intake (Fig. 1A, E).
There was no such decrease in female Y1Y52/2mice (Fig. 1C, G).
As hypothalamic NPY expression and Y receptor activation is
enhanced under fasting conditions [26,27], we hypothesised that
any differences in food intake between genotypes would be more
apparent after fasting. Indeed, both, male and female Y1Y52/2
mice at 18 weeks of age, and male Y1Y52/2 mice at 34 weeks of
age, showed significant reductions in food intake for up to 48 hours
after a 24-hour fast (Fig. 1B, D, F, H). This reduction in food
intake translated into delayed body weight recovery after fasting in
Y1Y52/2 versus wildtype mice (Fig. 2). Although male and female
Y1Y52/2 animals at 18 weeks of age lost a similar percent body
weight to wildtypes during the 24-hour fast, they exhibited
significantly reduced body weight – as a percent of pre-fasting
values – during the 48 hours of refeeding (Fig. 2A, B). This delayed
weight regain after fasting was also seen in male, but not female
Y1Y52/2 mice at 34 weeks of age (Fig. 2C, D). Furthermore, the
decreased food intake of Y1Y52/2 mice was associated with a
decrease in hypothalamic NPY mRNA expression in the arcuate
hypothalamic nucleus (ARC) (Fig. 3A, B; Table 1). Interestingly,
the mRNA expression of another known major hypothalamic
regulator of food intake – proopiomelanocortin (POMC) – was
unaltered in the ARC of Y1Y52/2 mice compared to wildtype
controls (Table 1), suggesting that lack of NPY signalling through
Y1 and Y5 receptors is sufficient to reduce food intake without any
concomitant increase in POMC production.
Interestingly, despite their significantly reduced food intake,
accelerated weight gain was observed in Y1Y52/2 mice from 5 to
15 weeks of age, particularly in males (Fig. 3C, D). Weekly body
weight measurements in a separate cohort of older mice, from 16
to 36 weeks of age, show that male but not female Y1Y52/2 mice
exhibited significantly increased body weight compared to wild-
type mice (Fig. 1I, J). Dual energy X ray absorptiometry (DXA)
revealed increases in fat mass as a percent of body weight when
measured at 20 and 36 weeks of age in Y1Y52/2 mice,
significantly so in females (Fig. 1K, M). This was confirmed by
regional white adipose tissue (WAT) dissection at 36 weeks of age
(Fig. 1L, N). Female but not male Y1Y52/2 animals demonstrated
a significant decrease in lean mass at 20 and 36 weeks of age
compared to wildtype counterparts, as determined with DXA
analysis (Fig. 1O, P). This may have contributed to the lack of
increase in body weight in older female Y1Y52/2 mice despite
increased adiposity.
Energy Expenditure and Respiratory Exchange Ratio are
Reduced in Germline Y1Y52/2 Mice
In order to investigate the discrepancy between reduced food
intake and elevated bodyweight gainwe used indirect calorimetry to
determine whether differences in energy metabolism may have
contributed to the increased body weight or adiposity of Y1Y52/2
mice despite reduced food intake. Energy expenditure was reduced
in Y1Y52/2 compared to wildtype mice at 20 weeks of age, and this
difference was statistically significant in males (Fig. 4A, C).
Conversely, energy expenditure was significantly increased in
female Y1Y52/2 versus wildtype mice at 36 weeks of age
(Fig. 4D). This effect was not seen in male double mutant mice of
the same age (Fig. 4B). These changes in energy expenditure were
not due to corresponding reductions in physical activity inY1Y52/2
mice of either sex or either age (Fig. 4E–H). In fact, physical activity
was significantly increased relative to wildtype values in female
Y1Y52/2 mice at 20 weeks of age (Fig. 4G). Respiratory exchange
ratio (RER), an index of fuel source, was significantly decreased in
both male and female Y1Y52/2 compared to wildtype mice at both
20 and 36 weeks of age, particularly during the dark phase (Fig. 4I–
L), suggesting a propensity for Y1Y52/2 mice to utilise more fat as
their oxidative fuel source compared to wildtype mice. It should be
noted that theRERdata in our studies, at times, exceeds a value of 1,
which is likely a reflection of lipogenesis taking place at that point in
time [28,29]. Taken together, these data show that Y1Y5 receptor
deletion inmice, especially males, results in greater body weight and
adiposity which occurs despite reduced spontaneous or fasting-
induced food intake, as well as a greater propensity to oxidise fat as a
fuel source. A possible contributor to this increased weight gain and
adiposity in Y1Y52/2mice, at least inmales, is the decreased energy
expenditure seen at the earlier age of 20 weeks.
Adult-onset Hypothalamus-specific Y1Y5 Receptor Dual
Ablation Reduces Food Intake
In order to determinewhether hypothalamicY1 andY5 receptors
are the critical components for the hypophagic effect of germline
double knockout, we studied adult-onset hypothalamus-specific
Y1Y5 deletedmice. For this, Y1Y5lox/lox mice were injected into the
hypothalamic paraventricular nucleus (PVN) region with a recom-
binant Cre-recombinase-expressing adeno-associated viral vector
(rAAV). These mice are referred to as Y1Y5Hyp/Hyp. Control mice
were injected with a GFP-expressing AAV. Delivery was targeted to
just above the PVN to avoid destruction of the nucleus, andwas close
enough to allow diffusion of the rAAV-Cre virus into the PVN, as
can be seen in Fig. 5A from the position of the needle track and of the
localised fluorescence from viral vector-derived GFP in this nucleus.
Hypothalamic gene deletion was confirmed using PCR amplifica-
tion of Y1 and Y5 receptors (Fig. 5B), demonstrating that Y1Y5
receptor deletion was specific to parts of the hypothalamus
containing the PVN, with no gene deletion occurring in parts of
the hypothalamus containing the olfactory bulb or the arcuate
nucleus, an area in close proximity to the targeted injection site (the
PVN). Radioactive ligand binding using 125[I]-peptide YY (PYY) to
detect total Y receptor binding (Fig. 5C), as well as in situ
hybridisation with oligonucleotides to detect Y1 and Y5 receptor
mRNA (Fig. 5D), demonstrate reduced total Y receptor binding and
reduced Y1 and Y5mRNA expression in the PVN of Y1Y52/2 and
Y1Y5Hyp/Hyp mice relative to wildtype controls, this change being
statistically significant for Y1Y5 mRNA levels (Fig. 5D). As Y1 and
Y5 receptors are the predominant Y receptors expressed in the PVN
[30], these changes in total Y receptor binding and Y1Y5 mRNA
expression in the PVN thereby confirm effectiveY1Y5 receptor gene
receptors in both brain regions in these mice. In contrast, when oligonucleotides A+D are used, a PCR product is produced only from DNA isolated
from sections of the hypothalamus containing the PVN (H) of Y1Y52/2 and Y1Y5Hyp/Hyp mice, and not from WT mice or from sections of the
hypothalamus containing the olfactory bulb (O) or the arcuate nucleus (A) of Y1Y5Hyp/Hyp mice, demonstrating successful deletion of the Y1 and Y5
genes specifically from the targeted PVN region. (C) 125[I]-peptide YY (PYY) binding levels in the PVN of wildtype (Y1Y5WT), Y1Y52/2 or Y1Y5Hyp/Hyp
mice. (D) Y1Y5 mRNA expression in the PVN of Y1Y5WT, Y1Y52/2 and Y1Y5Hyp/Hyp mice after subtraction of Y1Y52/2 values as a background control.
(E) 125[I]-PYY binding levels in the arcuate nucleus of Y1Y5WT, Y1Y52/2 and Y1Y5Hyp/Hyp mice. Plotted values are means 6 SEM of the averages of 2–
7 mice per group, with 3–9 separate measurements per mouse. *P,0.05, ***P,0.001 versus WT mice. Abbreviations: 3V, third ventricle; PVN,
hypothalamic paraventricular nucleus.
doi:10.1371/journal.pone.0040191.g005
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knockdown in the hypothalamus of Y1Y5Hyp/Hyp mice. To
investigate possible effects of Y1Y5 receptor deletion on the
expression of other Y receptors in a key brain region regulating
energy homeostasis, wemeasured 125[I]-PYY binding in the arcuate
nucleus of our mouse models, providing an index of total Y receptor
binding in this region. We also specifically investigated changes in
Figure 6. No effect of adult-onset hypothalamus-specific Y1Y5 receptor deletion on energy homeostasis on a chow diet. (A–H)
Spontaneous (A, C, E, G) and accumulated (accum) 24-hour fasting-induced food intake (B, D, F, H), normalised to body weight, in adult-onset
hypothalamus-specific Y1Y5 receptor deficient (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice at 18 and 34 weeks of age. (I–J) Body weight from 12 to 36
weeks of age in male (I) and female (J) Y1Y5Hyp/Hyp or Y1Y5lox/lox control mice. ‘PVN injection’ refers to the time of induction of gene deletion by
injection of a Cre-recombinase-expressing viral vector into the paraventricular nucleus of the hypothalamus. (K–P) Fat and lean masses as a
percentage of body weight (%BW), measured using dual energy x-ray absorptiometry, in male (K, O) and female (M, P) Y1Y5Hyp/Hyp and Y1Y5lox/lox
mice at 19, 27 and 36 weeks of age. Weight (as %BW) of dissected white (WAT) and brown adipose tissue (BAT) depots at the end of the study in male
(L) and female (N) Y1Y5Hyp/Hyp and Y1Y5lox/lox mice at 36 weeks of age. Abbreviations: i, inguinal; g, gonadal; m, mesenteric; r, retroperitoneal; total,
summed weight of i, g, m and r WAT depots. Plotted values are means 6 SEM of 5–12 standard chow-fed mice per group.
doi:10.1371/journal.pone.0040191.g006
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Figure 7. Obesity despite hypophagia after adult-onset hypothalamus-specific Y1Y5 deletion in mice on a high fat diet. (A–H)
Spontaneous (A, C, E, G) and accumulated (accum) 24-hour fasting-induced food intake (B, D, F, H), normalised to body weight, in adult-onset
hypothalamus-specific Y1Y5 receptor deficient (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice at 18 and 34 weeks of age. (I–J) Body weight from 12 to 36
weeks of age in male (I) and female Y1Y5Hyp/Hyp or Y1Y5lox/lox mice. Mice were on the high fat diet (HFD) from 16 weeks of age onwards. ‘PVN
injection’ refers to the time of induction of gene deletion by injection of a Cre-recombinase-expressing viral vector into the paraventricular nucleus of
the hypothalamus. (K–P) Fat and lean masses as a percentage of body weight (%BW), measured using dual energy x-ray absorptiometry, in male (K,
O) and female (M, P) Y1Y5Hyp/Hyp and Y1Y5lox/lox mice at 19, 27 and 36 weeks of age. Weight (as %BW) of dissected white (WAT) and brown adipose
tissue (BAT) depots at the end of the study in male (L) and female (N) Y1Y5Hyp/Hyp and Y1Y5lox/lox mice at 36 weeks of age. Abbreviations: i, inguinal; g,
gonadal; m, mesenteric; r, retroperitoneal; total, summed weight of i, g, m and r WAT depots. Plotted values are means 6 SEM of 5–12 HFD-fed mice
per group. *P,0.05 or **P,0.01 for Y1Y5Hyp/Hyp versus Y1Y5lox/lox mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g007
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Y2 receptor binding in the arcuate nucleus of our mice by
determining the degree to which 125[I]-PYY binding was displaced
by the Y2-preferring antagonist, BIIE0246. We did not specifically
investigate Y4 or y6 binding because Y4 receptors represent only a
very small percentage of Y receptors in the brain and specifically in
the hypothalamus [30], and because y6 receptors are only found in
the suprachiasmatic nucleus [31]. However, neither of our Y1Y5
deficient models demonstrated significant differences from wildtype
mice with respect to total Y receptor binding (Fig. 5E) nor Y2
receptor binding (data not shown) in the arcuate nucleus.
At 16 weeks of age, corresponding to 4 weeks after stereotaxic
brain injection, half of the Y1Y5lox/lox and Y1Y5Hyp/Hyp animals
were placed on a high fat diet (HFD) for 20 weeks. The remaining
mice were continued on the standard chow diet. We investigated
all mice at 1–3 and 18–20 weeks after commencement of the
HFD, corresponding to 17–19 and 34–36 weeks of age,
respectively. On the standard chow diet, Y1Y5Hyp/Hyp mice
exhibited no significant differences in food intake, albeit there was
a trend to reduced fasting-induced food intake (Fig. 6A–H). When
fed the HFD, however, male and female mice with hypothalamic
Y1Y5 receptor deficiency exhibited a significantly reduced
spontaneous and/or fasting-induced food intake when investigated
at 34 (Fig. 7E–H) but not at 17 weeks of age (Fig. 7A–D).
As in the Y1Y52/2 mice, 17 week-old male Y1Y5Hyp/Hyp mice
on a standard chow diet lost a similar proportion of their body
weight in response to fasting as wildtypes, and exhibited delayed
body weight recovery during refeeding (Fig. 8A), albeit this effect
was not seen in chow-fed male mice at the later time point of 34
weeks, nor in high fat-fed males, nor in female Y1Y5Hyp/Hyp mice
on either diet or at either time point (Fig. 8B-H). In fact, female
Y1Y5Hyp/Hyp mice on either diet exhibited significantly faster
body weight recovery than their wildtype counterparts (Fig. 8B, F).
Unlike the Y1Y52/2 mice, the body weight, adiposity and lean
mass of male and female Y1Y5Hyp/Hyp mice on the standard chow
Figure 8. Effect of adult-onset hypothalamus-specific Y1Y5 receptor deletion on weight regain after a 24-hour fast. Body weight
measurements were taken at the time points of fasting-induced food intake measurements in male (A, C, E, G) and female (B, D, F, H) adult-onset
hypothalamus-specific Y1Y5 receptor knockout (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice, at both 17 and 34 weeks of age and on a standard chow
(Chow) or a high fat diet (HFD). Data are represented as a percent of pre-fasting body weight (%basal). Absolute pre-fasting body weights at 17
weeks of age were Y1Y5lox/lox male = 25.460.6 g (standard chow), 28.060.6 g (HFD); Y1Y52/2male = 26.160.9 g (standard chow), 28.960.9 g (HFD);
Y1Y5lox/lox female = 20.160.5 g (standard chow), 21.661.0 g (HFD); Y1Y52/2 female = 20.160.6 g (standard chow), 21.660.8 g (HFD), and at 34
weeks of age were Y1Y5lox/lox male = 30.061.3 g (standard chow), 34.061.5 g (HFD); Y1Y52/2male = 31.261.6 g (standard chow), 40.261.6 g (HFD);
Y1Y5lox/lox female = 24.760.7 g (standard chow), 27.961.5 g (HFD); Y1Y52/2 female = 27.162.0 g (standard chow), 29.961.3 g (HFD). Plotted values
are means 6 SEM of 4–21 mice per group. *P,0.05 for Y1Y5Hyp/Hyp versus Y1Y5lox/lox mice of the same age, sex and diet.
doi:10.1371/journal.pone.0040191.g008
Figure 9. Unaltered energy expenditure and decreased physical activity in chow-fed mice with adult-onset hypothalamus-specific
Y1Y5 receptor deletion. (A–L) 24-hour time course of energy expenditure (A–D), physical activity (E–H) and respiratory exchange ratio (I–L) in male
and female adult-onset hypothalamus-specific Y1Y5 receptor knockout (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice at 19 and 36 weeks of age. Energy
expenditure was adjusted for lean mass by analysis of covariance (ANCOVA). Adjusted energy expenditure was presented at a common lean mass of
21.629 g (males) and 16.252 g (females) at 19 weeks of age and 22.762 g (males) and 18.865 g (females) at 36 weeks of age. Open and filled
horizontal bars indicate light and dark phases, respectively. Plotted values are means 6 SEM of 5–12 standard chow-fed mice per group. *P,0.05 or
**P,0.01 for Y1Y5Hyp/Hyp versus Y1Y5lox/lox mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g009
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diet was not statistically different from corresponding measures in
Y1Y5lox/lox controls (Fig. 6I–P). In contrast, and despite concom-
itant hypophagia, the body weight of male and female Y1Y5Hyp/
Hyp mice on a HFD was significantly greater than that of Y1Y5lox/
lox controls (Fig. 7I, J). Male but not female Y1Y5Hyp/Hyp mice on
a HFD exhibited a significant increase in percent fat mass as
determined by DXA (Fig. 7K, M), as well as a significant increase
in the relative weight of dissected WAT depots relative to control
animals (Fig. 7L, N). Lean mass was no different in Y1Y5Hyp/Hyp
mice compared to controls at 19, 27 or 36 weeks of age (Fig. 7O,
P).
Altered Energy Expenditure and Physical Activity in
Hypothalamus-specific Y1Y5 Receptor Knockout Mice
On the normal chow diet, Y1Y5Hyp/Hyp mice showed no
significant difference in energy expenditure relative to wildtype
values (Fig. 9A–D). Physical activity was decreased in male and
female Y1Y5Hyp/Hyp versus control mice on the standard chow
diet at either 19 and/or 36 weeks of age (Fig. 9E–H). On the HFD,
energy expenditure was significantly increased in male but not
female Y1Y5Hyp/Hyp relative to Y1Y5lox/lox control mice at both
19 weeks of age, after 3 weeks on the HFD, as well as at 36 weeks
of age, after 20 weeks on the HFD (Fig. 10A–D). These changes in
energy expenditure were associated with corresponding increases
in physical activity in male Y1Y5Hyp/Hyp mice at 19 weeks of age,
as well as in male and female Y1Y5Hyp/Hyp mice at 36 weeks of
age, significantly so in females (Fig. 10E–H). Unlike germline
Y1Y52/2 mice, which showed significant decreases in RER, there
was no general significant difference between Y1Y5Hyp/Hyp and
control mice on the chow diet or HFD with respect to RER, apart
from a similar significant decrease in RER during the light phase
in HFD-fed female Y1Y5Hyp/Hyp mice at 19 weeks of age, as well
as a small but significant increase in RER in chow-fed female
knockouts at 36 weeks of age (Fig. 9I–L, Fig. 10I–L). These
differences between germline and hypothalamus-specific Y1Y5
receptor knockout mice with respect to RER suggest that it is not
the hypothalamic Y1Y5 receptors that control fuel oxidation
source, but this is instead controlled by Y1Y5 receptors located
outside of this area.
Involvement of Hypothalamic Y1Y5 Receptors in
Regulation of Glucose Metabolism
Since overweight or obese individuals often exhibit glucose
intolerance and signs of insulin resistance, and as hypothalamic
Y1 and Y5 receptors are implicated in the regulation of glucose
homeostasis [32], we measured several parameters of glucose
metabolism in Y1Y5Hyp/Hyp mice. After intraperitoneal glucose
injection, female but not male Y1Y5Hyp/Hyp mice on a standard
chow diet at 18 but not 35 weeks of age demonstrated
significantly higher serum glucose levels (Fig. 11A–D). No such
genotype effect was observed in mice on the HFD (Fig. 11E–H).
After intraperitoneal insulin injection, male Y1Y5Hyp/Hyp mice
displayed a significantly blunted drop in serum glucose levels,
and this difference was significant at 18 weeks of age on the
standard chow diet (Fig. 11I) and at 35 weeks old on the HFD
Figure 10. Increased energy expenditure/physical activity in high fat-fed mice with adult-onset hypothalamus-specific Y1Y5
receptor deletion. (A–L) 24-hour time course of energy expenditure (A–D), physical activity (E–H) and respiratory exchange ratio (I–L) in male and
female adult-onset hypothalamus-specific Y1Y5 receptor knockout (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice on a high fat diet (HFD) at 19 and 36
weeks of age. Energy expenditure was adjusted for lean mass by analysis of covariance (ANCOVA). Adjusted energy expenditure was presented at a
common lean mass of 20.741 g (males) and 15.607 g (females) at 19 weeks of age and 21.636 g (males) and 17.320 g (females) at 36 weeks of age.
Open and filled horizontal bars indicate light and dark phases, respectively. Plotted values are means 6 SEM of 5–12 HFD-fed mice per group.
*P,0.05 or ***P,0.001 for Y1Y5Hyp/Hyp versus Y1Y5lox/lox mice of the same age and sex.
doi:10.1371/journal.pone.0040191.g010
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(Fig. 11N). No such effect of hypothalamic Y1Y5 dual deletion
was seen in female mice (Fig. 11K, L, O, P).
Discussion
This study for the first time conclusively demonstrates that food
intake in mice requires the coordinated action of both the Y1 and
the Y5 receptors, since the simultaneous ablation of both receptors
in germline Y1Y5 receptor double knockout (Y1Y52/2) mice lead
to reductions in spontaneous and/or fasting-induced food intake at
18 or 34 weeks of age, as well as corresponding delays in weight
regain after fasting. This hypophagic effect of germline Y1Y5
ablation is at least partially mediated in the hypothalamus, because
mice with adult-onset hypothalamus-specific Y1Y5 receptor dual
ablation also exhibited reduced fasting-induced and/or spontane-
ous food intake at 34 weeks of age and under conditions of a high
fat diet (HFD). Despite hypophagia, Y1Y5 deficient mice exhibited
increased body weight and/or increased adiposity. This obesity
was more apparent in germline than in adult-onset hypothalamus-
specific Y1Y5 deficient mice – the latter model exhibiting obesity
only on a HFD and not on normal chow – possibly due to
compensatory responses to gene deletion such as the decrease in
energy expenditure observed in male Y1Y52/2 mice. Taken
together, these data reveal the coordinated role of Y1 and Y5
receptors in the physiological regulation of food intake in mice.
The strong hypophagic phenotype of our Y1Y5 double
knockout models suggests that Y1 and Y5 receptors play
redundant roles in the regulation of food intake. Whereas single
germline deletion of Y1 receptors in male and female mice has
been consistently shown to reduce fasting-induced but not
spontaneous food intake [13–16], and whereas single germline
deletion of Y5 receptors actually increases spontaneous and fasting-
induced food intake in both sexes [17,18], our male germline
Y1Y5 receptor double knockout mice exhibited hypophagia under
both fasted and non-fasted conditions. These findings imply that
when either the Y1 or the Y5 receptor is missing, the remaining
Figure 11. Altered blood glucose responses to glucose and insulin after adult-onset hypothalamus-specific Y1Y5 receptor deletion.
(A–H) Intraperitoneal glucose tolerance tests (1 g/kg) were conducted in 24-hour fasted male (A, B, E, F) and female (C, D, G, H) adult-onset
hypothalamus-specific Y1Y5 receptor deficient (Y1Y5Hyp/Hyp) or control (Y1Y5lox/lox) mice at 18 or 35 weeks of age. (I–P). Intraperitoneal insulin
tolerance tests (0.5 U/kg) were conducted in 6-hour fasted male (I, J, M, N) and female (K, L, O, P) Y1Y5Hyp/Hyp or control Y1Y5lox/lox mice at 18 or 35
weeks of age. Plotted values are means 6 SEM of 5–12 chow or high fat diet (HFD)-fed mice per group. *P,0.05 or **P,0.01 for Y1Y5Hyp/Hyp versus
Y1Y5lox/lox mice of the same age, sex and diet.
doi:10.1371/journal.pone.0040191.g011
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receptor is able to compensate or overcompensate to protect
against hypophagia. When both receptors are missing, hypophagia
ensues, significantly so in males.
It is noteworthy that the hypophagic effect of dual Y1Y5
receptor deletion was more marked in germline than in adult-onset
hypothalamus-specific knockout mice. Indeed, the latter model
only demonstrated significant reductions in spontaneous or fasting-
induced food intake on a HFD but not when fed normal chow,
and this effect was only observed at 22 but not at 5 weeks after
induction of gene deletion, corresponding to 18 and 1 week on the
HFD, respectively. One possible explanation for this discrepancy
between models is that the rAAV-derived Cre-recombinase
deleted Y1 and Y5 receptors only from a proportion of the PVN
neurons targeted in this study. While brain injection of Cre-
recombinase-producing adenoviral vectors into conditional knock-
out mice has been shown to induce gene deletion in up to 90% of
neurons [33], we cannot exclude the possibility that our bilaterally-
injected rAAV expressing Cre-recombinase did not reach all
neurons of the PVN. Also, other areas of the brain besides the
PVN are involved in the regulation of feeding, particularly under
non-fasted conditions. For instance, NPY-ergic projections to the
dorsomedial nucleus of the hypothalamus (DMN) and the
ventromedial hypothalamus (VMH) have been implicated in
appetite regulation [34], and both of these nuclei are known to
express Y1 and/or Y5 receptor mRNA [35,36]. Studies targeting
Y1Y5 receptor deletion in regions such as the DMN and VMH
would shed light on this issue.
While we have shown that dual Y1 and Y5 receptor ablation is
the primary defect leading to hypophagia in our mouse models,
the exact pathway leading to hypophagia is likely to be more
complex than a simple lack of NPY signalling via Y1 and Y5
receptors. For instance, germline Y1Y52/2 mice demonstrated
decreased NPY mRNA expression in the hypothalamic arcuate
nucleus. It was previously shown that NPY-ergic neurons in the
arcuate nucleus inhibit the activity of neighboring POMC
neurons, thereby dampening a-MSH-induced inhibition of food
intake [37]. As such, reduced arcuate NPY expression in our
Y1Y5 deficient mice could result in relative dis-inhibition of
neighboring POMC neurons, which in itself could contribute to
the observed hypophagia. It might be argued that the reduction in
NPY expression in our Y1Y52/2 mice is due to enhanced
inhibitory action of the Y2 auto-receptor on these neurons, in
keeping with the observation that deletion of Y1 receptors leads to
up-regulation of Y2 receptor expression [38]. However, our Y
receptor binding studies revealed no such evidence of Y2 receptor
up-regulation in our Y1Y5 deficient mouse models, which on the
other hand does not exclude increased activity. An additional
potential contributor to the hypophagic phenotype of our Y1Y5
receptor deficient mice is concomitant obesity, which would be
expected to induce hormonal changes known to reduce food
intake, such as elevated circulating concentrations of leptin and the
gut satiety hormone peptide YY [39–42]. However, obesity is not
the only mechanism for hypophagia in our mice, because 18 week-
old male Y1Y52/2 mice on a chow diet exhibited clear
hypophagia under both fasted and non-fasted conditions, despite
the fact that they were not yet obese at this age.
Despite hypophagia, both germline and hypothalamus-specific
Y1Y5 receptor knockout mice became obese. This was particularly
apparent in the germline model, in which body weight was
increased in mice on a normal chow diet from as young as 5 weeks
of age onwards. In contrast, hypothalamus-specific knockout mice
demonstrated increased body weight and/or adiposity only under
conditions of high fat feeding, not on a normal chow diet. This
early-onset obesity in germline knockouts may be due to
compensatory responses to gene deletion, as has been observed
in germline Y5 receptor knockout mice which exhibit exacerbated
fasting-induced increases in hypothalamic expression of NPY and
AgRP and exacerbated decreases in that of POMC and CART
[18]. In keeping with the possibility of compensatory and
obesogenic responses to gene deletion, male but not female
Y1Y52/2 mice exhibited significant reductions in energy expen-
diture, albeit hypothalamic arcuate nucleus (ARC) NPY mRNA
levels were decreased and ARC POMC mRNA levels were
unchanged in this model. One could hypothesise that up-
regulation of other Y receptors may be compensating for the lack
of Y1 and Y5 receptors in our knockout models, as was previously
observed in Y12/2 mice which exhibited increased Y2 receptor
mRNA and protein levels compared to wildtype controls [38].
However, our binding studies revealed no change in total or Y2-
specific binding in the arcuate nucleus of our Y1Y5 deficient
mouse models, demonstrating that any adaptive changes contrib-
uting to obesity probably do not involve alterations in Y receptor
expression. In the female Y1Y52/2 mice, as well as in the
hypothalamus-specific knockout model on a HFD, other changes
besides reduced energy expenditure must have contributed to the
exacerbated diet-induced obesity, as energy expenditure was either
unchanged or significantly increased in these animals. Compen-
satory responses to dual Y1Y5 receptor ablation, whether germline
or conditional, may originate from other central and peripheral
systems that work with NPY to modulate energy balance. These
include several other peptide and hormone signaling systems such
as those of leptin, melanocortins, adiponectin and sex hormones
[43]. Regardless of the underlying mechanisms, our observation of
increased body weight and/or adiposity in Y1Y5 knockout mice
despite decreased food intake and/or – in the case of older female
Y1Y52/2 mice and male Y1Y5Hyp/Hyp mice on a HFD –
increased energy expenditure, provide further support for the
hypothesis that energy homeostatic systems are indeed biased
towards the development of obesity [44].
Taken together, the findings from these studies demonstrate that
dual deletion of Y1 and Y5 receptors, either globally or within the
hypothalamus, results in marked and significant reductions in food
intake, revealing a coordinated role of Y1 and Y5 in the regulation
of appetite.
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